SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $924,783 | -60.2% | 44,936 | -9.0% | 0.00% | -57.1% |
Q2 2023 | $2,322,130 | +12.1% | 49,386 | -0.0% | 0.01% | +16.7% |
Q1 2023 | $2,072,320 | +1.2% | 49,388 | -8.0% | 0.01% | -14.3% |
Q4 2022 | $2,046,936 | -2.9% | 53,669 | -0.3% | 0.01% | 0.0% |
Q3 2022 | $2,107,000 | +13.6% | 53,808 | -6.3% | 0.01% | +40.0% |
Q2 2022 | $1,854,000 | +17.5% | 57,413 | +20.4% | 0.01% | +66.7% |
Q1 2022 | $1,578,000 | +493.2% | 47,675 | +663.2% | 0.00% | +200.0% |
Q4 2021 | $266,000 | -6.7% | 6,247 | -3.0% | 0.00% | 0.0% |
Q3 2021 | $285,000 | -18.3% | 6,440 | +5.0% | 0.00% | 0.0% |
Q2 2021 | $349,000 | -28.2% | 6,136 | -5.5% | 0.00% | 0.0% |
Q1 2021 | $486,000 | -14.7% | 6,490 | -1.4% | 0.00% | 0.0% |
Q4 2020 | $570,000 | +36.0% | 6,584 | -3.9% | 0.00% | 0.0% |
Q3 2020 | $419,000 | +48.6% | 6,854 | +0.9% | 0.00% | 0.0% |
Q2 2020 | $282,000 | +39.6% | 6,794 | -3.4% | 0.00% | 0.0% |
Q1 2020 | $202,000 | -91.0% | 7,034 | -77.4% | 0.00% | -83.3% |
Q4 2019 | $2,246,000 | +124.2% | 31,106 | +335.4% | 0.01% | +100.0% |
Q3 2019 | $1,002,000 | -24.0% | 7,144 | -0.8% | 0.00% | -25.0% |
Q2 2019 | $1,318,000 | -9.1% | 7,198 | -21.0% | 0.00% | 0.0% |
Q1 2019 | $1,450,000 | +73.7% | 9,115 | +4.6% | 0.00% | +33.3% |
Q4 2018 | $835,000 | -32.2% | 8,715 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $1,231,000 | -11.7% | 8,715 | -2.2% | 0.00% | -25.0% |
Q2 2018 | $1,394,000 | -79.9% | 8,908 | -79.3% | 0.00% | -80.0% |
Q1 2018 | $6,926,000 | +10.7% | 43,000 | +13.2% | 0.02% | +17.6% |
Q4 2017 | $6,259,000 | +201.3% | 38,000 | +14.0% | 0.02% | +183.3% |
Q3 2017 | $2,077,000 | +4.3% | 33,334 | +33.3% | 0.01% | 0.0% |
Q2 2017 | $1,991,000 | – | 25,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |